RNA therapeutics
RNA therapeutics is a rapidly evolving field of medicine that uses RNA (ribonucleic acid) molecules to treat diseases. RNA therapeutics can be used to target specific genetic processes involved in disease progression, offering a new approach to treatment.
Overview[edit | edit source]
RNA therapeutics involves the use of RNA molecules as therapeutic agents. This can include small interfering RNA (siRNA), microRNA (miRNA), antisense RNA, and messenger RNA (mRNA). These RNA molecules can be used to target specific genes, regulating their expression and thereby influencing disease processes.
Types of RNA Therapeutics[edit | edit source]
Small Interfering RNA (siRNA)[edit | edit source]
Small interfering RNA (siRNA) is a type of RNA molecule that can interfere with the expression of specific genes. It works by binding to mRNA molecules and preventing them from being translated into proteins. This can be used to reduce the production of harmful proteins that contribute to disease.
MicroRNA (miRNA)[edit | edit source]
MicroRNA (miRNA) is another type of RNA molecule that can regulate gene expression. miRNAs work by binding to mRNA molecules and preventing their translation. They can also promote the degradation of mRNA, further reducing protein production.
Antisense RNA[edit | edit source]
Antisense RNA is a type of RNA molecule that can bind to mRNA molecules and prevent their translation. This can be used to reduce the production of harmful proteins.
Messenger RNA (mRNA)[edit | edit source]
Messenger RNA (mRNA) is a type of RNA molecule that carries the genetic information from DNA to the ribosome, where it is translated into protein. mRNA therapeutics can be used to increase the production of beneficial proteins.
Applications[edit | edit source]
RNA therapeutics has potential applications in a wide range of diseases, including cancer, genetic disorders, infectious diseases, and autoimmune diseases. By targeting specific genes, RNA therapeutics can offer a more targeted approach to treatment, potentially reducing side effects and improving patient outcomes.
Challenges[edit | edit source]
Despite the potential of RNA therapeutics, there are several challenges that need to be overcome. These include the delivery of RNA molecules to the target cells, the stability of RNA molecules in the body, and the potential for off-target effects.
See Also[edit | edit source]
RNA therapeutics Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD